Memory gummies typically lack scientific evidence to support dementia prevention or memory improvement claims, and major brands have faced FDA enforcement for making unsupported promises. Standard multivitamins show more substantial benefit in large rigorous trials—the COSMOS study of 21,442 people found daily multivitamin use improved memory equivalent to 3.1 years of aging and slowed overall cognitive decline by 2 years—though the effect is modest and not specific to dementia.
The difference comes down to study rigor and regulatory oversight, not ingredient type. Memory gummies are marketed without FDA pre-market approval and often tested in small, short trials prone to bias; multivitamins in large, long-term trials show clearer (though still modest) benefit. If you're considering either for memory concerns, understanding what the evidence actually shows—and what it does not—is essential before choosing.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the evidence actually shows for memory gummies
- Why supplements can make claims without FDA approval
- How standard multivitamins compare in evidence
- Why study quality explains the conflicting evidence
- How to identify credible memory and cognitive supplement claims
- Frequently Asked Questions
What the evidence actually shows for memory gummies
The FDA ordered Prevagen's maker to stop claiming the supplement improves memory in December 2024, after seven years of litigation found advertising claims lacked competent scientific evidence. The ingredient (apoaequorin, a protein from jellyfish) had never been consumed by humans before commercialization. This is not an isolated case: the FDA has sent over 40 warning letters to companies illegally marketing 80+ memory supplement products with false efficacy claims.
For ginkgo biloba—one of the most studied botanical memory ingredients—a 2026 Cochrane systematic review of 82 randomized trials found very weak evidence of cognitive benefit in people with subjective memory complaints. The median trial enrolled only 92 participants with common bias issues like inadequate blinding and no pre-registration. For people already diagnosed with dementia, ginkgo may modestly improve cognitive function and daily activities over six months versus placebo, but effects were inconsistent and no supplement prevents dementia onset.
Why supplements can make claims without FDA approval
Memory supplements are regulated as food, not drugs, and require no FDA approval before sale. Under the Dietary Supplement Health and Education Act (DSHEA, passed in 1994), manufacturers bear responsibility for safety and truthful claims; the FDA only acts after a product reaches market and only when it finds evidence of fraud or harm. This is why Prevagen sold for years with memory-improvement claims before court action forced the company to stop—the burden of proof fell on regulators, not the seller.
This framework means hundreds of unproven memory products can launch and advertise openly. Once a product gains visibility or sales volume, FDA and state attorneys general (like New York's office in the Prevagen case) may investigate. But by that point, millions of consumers have already purchased based on claims the science does not support.
How standard multivitamins compare in evidence
Standard multivitamins show a different pattern in rigorous trials. The COSMOS trial, published in 2024, followed 21,442 people for three years with a pre-registered protocol (meaning the research plan was locked in before results were known).
Participants taking a daily multivitamin showed memory improvement equivalent to slowing cognitive aging by 3.1 years and overall cognitive decline slowed by 2 years compared to placebo, with no notable adverse effects maintained across all three years. This benefit is modest—not a cure and not a substitute for treating dementia—but it is consistent and detected in a much larger, longer, more rigorous study than most memory-gummy trials. The effect size is comparable to what some interventions (like aerobic exercise) show for cognitive aging, and it persists when measured objectively rather than by self-report alone.
Why study quality explains the conflicting evidence
Most memory-gummy trials enroll 40–150 participants for 8–12 weeks with methodological problems including inadequate blinding, lack of pre-registration, and reliance on self-reported memory complaints rather than objective testing. COSMOS enrolled over 21,000 people followed for three years with objective cognitive testing and a pre-registered analysis plan.
The rigor difference, not the supplement type, often predicts whether a trial detects benefit. Small, short, unregistered trials are prone to bias in multiple directions: participants in supplement groups may report more improvement if they know they received an active ingredient (even placebo); researchers may unconsciously record or analyze data in ways that favor results supporting their hypothesis; and studies showing no effect are less likely to be published or promoted, making published results appear stronger than they actually are. When a memory-gummy trial reports dramatic improvements in eight weeks and a multivitamin trial in 21,000 people over three years reports modest improvements, the study design itself predicts much of the difference.
How to identify credible memory and cognitive supplement claims
When you encounter a memory supplement claim, check three things: For cognitive health broadly, the strongest evidence supports proven interventions outside supplements: regular aerobic exercise, cognitive engagement (learning new skills), sleep, social connection, and management of cardiovascular risk factors like blood pressure and cholesterol. If you are considering a memory supplement alongside or instead of these, ask a primary care provider or neurologist whether the supplement is appropriate for your individual health profile and medications.
- **Was the claim challenged by FDA or the FTC?** Search the company name plus "FDA warning letter" or "FTC lawsuit." If the product is actively marketed with a recent court loss against it (as with Prevagen), the advertising likely outpaces evidence.
- **How large was the trial and how long did it run?** A trial with 50 people followed for six weeks tells you far less than a trial with 500 people followed for one year. Published company-funded studies are often small; independent researcher-led trials and systematic reviews of many trials together are more reliable.
- **Was the trial pre-registered and were objective measures used?** If the study plan was filed before results were known and memory was tested with cognitive tests (not just self-reported feeling) the findings are more trustworthy.
Frequently Asked Questions
If Prevagen was found to have unsupported claims, why is it still being sold?
The December 2024 court order required the maker to stop advertising specific memory-improvement claims and to remove the product from store shelves in the short term. Regulatory enforcement is often slow—the lawsuit took seven years—and companies sometimes appeal or reformulate to work around restrictions.
Can a supplement both help with memory and not prevent dementia?
Yes. A supplement might modestly improve cognitive function in someone who already has mild cognitive decline or early dementia without preventing dementia's onset in people with normal memory. Ginkgo biloba appears to fit this pattern: weak evidence for prevention in healthy people, possible modest benefit for those already diagnosed.
Does the COSMOS multivitamin benefit apply to people with dementia or just healthy older adults?
COSMOS enrolled generally healthy older adults without existing dementia diagnosis; researchers did not study whether multivitamins benefit people already diagnosed with dementia or mild cognitive impairment, so the findings do not directly answer that question.
If multivitamins show benefit in COSMOS, why not just take them?
Multivitamins are generally safe and show modest documented benefit in one large trial, so many people choose to take them. The benefit is measurable but small—roughly equivalent to slowing aging by 2 years over three years—and not a substitute for exercise, sleep, cardiovascular health management, or evaluation by a doctor if you notice memory changes.
